Stock Analysis·← Pickers

CLPT

ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. (CLPT) is currently in a range/mixed trend, trading above both the 50-day and 200-day moving averages. RSI is at 46.2, with 2/3 trend checks passing.

Price
$15.67
2026-07-16
Trend score
2/3
Range / Mixed
RSI (14)
46.2
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

CLPT with MA50 and MA200

29.6024.3719.1313.898.6607/3110/2401/2204/1707/15
CLPT2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$14.41+8.72% vs price
MA200
$14.85+5.54% vs price
RSI (14)
46.2Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for CLPT

ClearPoint Neuro, Inc. (CLPT) looks more range-bound than strongly trending, but there are still a few supportive signs on the chart. The latest available price is $15.67, and 2 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 8.7% and above the 200-day moving average by 5.5%.

Momentum and stretch context

CLPT currently has an RSI reading of 46.2, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

This page is designed to help you quickly understand what the CLPT chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.

Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph Michael Burnett
Employees
172
Market cap
$469.9M
Beta
1.24
52-week range
$8.27 – $30.10
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
22 May 2012
ISIN
US18507C1036
CUSIP
18507C103
Company profile data from Financial Modeling Prep. CLPT listed on NASDAQ.
Share dilution

CLPT shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
29.5M
Since Jun 2019
+140.2%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. CLPT28 data points from Jun 2019 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about CLPT

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.